Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

January 30, 2024

https://www.globenewswire.com/news-release/2024/01/30/2820501/32920/en/Exagen-Inc-to-Participate-in-the-2024-BTIG-MedTech-Digital-Health-Life-Science-Diagnostic-Tools-Conference.html

CARLSBAD, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq:XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which takes place February 13-14, 2024 in Snowbird, Utah. John Aballi, Exagen’s President and Chief Executive Officer, and Kamal Adawi, Exagen’s Chief Financial Officer, will be participating in one-on-one meetings with investors during the event; meetings can be requested through BTIG.

Read more at globenewswire.com

Related news for (XGN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.